Shizuoka, Japan

Yasuhiro Ichida

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Yasuhiro Ichida: Innovator in Pharmaceutical Development

Introduction

Yasuhiro Ichida is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating various medical conditions. His work exemplifies the intersection of scientific research and practical application in healthcare.

Latest Patents

Ichida holds a patent for a dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same. This invention provides a compound that serves as a sodium-dependent phosphate transporter inhibitor. It is designed to be a preventive and/or therapeutic agent for conditions such as hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification. The patent highlights the compound's potential as an active ingredient in pharmaceutical drugs and compositions.

Career Highlights

Yasuhiro Ichida is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company in Japan. His role at the company has allowed him to focus on research and development, contributing to advancements in medical treatments. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Ichida has worked alongside notable colleagues such as Yoshihito Ohtake and Naoki Okamoto. Their collaborative efforts have fostered an environment of innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Yasuhiro Ichida's contributions to pharmaceutical innovation demonstrate the importance of research in addressing critical health issues. His patented work on dihydropyridazine-3,5-dione derivatives showcases his commitment to improving patient outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…